… SARS-CoV-2 is a novel RNA coronavirus of the same family as SARS-CoV and Middle
East respiratory syndrome coronavirus that mainly spreads through the respiratory tract [6]. …

… to SARS-CoV-2 infection (including ARDS in 2 patients), except 2 patients diagnosed
with lupus … The most frequently reported blood count abnormality in patients with SARS-CoV-2 …

… lupus erythematosus (SLE) comprise a unique population with regard to risk for infection and
outcomes associated with SARS–CoV-… protection against reinfection with SARS–CoV-2, as …

… SARS-CoV-2 infection determined autoimmune flares in a small number of patients. Our …
an increased risk of SARS-CoV-2 in SLE. Patients with asymptomatic SARS-CoV-2 infections …

… To evaluate the incidence and characteristics of SARS-CoV-2 infection among patients
with systemic lupus erythematosus (SLE) and to compare it to that described in the general …

Systemic lupus erythematosus (SLE) is a multisystem … Few cases of SLE occurring after
SARS‐CoV‐2 mRNA have … receiving the second dose of the SARS‐CoV‐2 mRNA‐1273 vaccine. …

… of 589 people without systemic lupus erythematosus. The … individuals with systemic lupus
erythematosus were at a much … systemic lupus erythematosus in the times of the SARS-CoV-2 …

… Coronavirus disease 2019 (COVID-19), a newly emerged respiratory disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2)… Systemic lupus erythematosus (…

… lupus erythematosus (SLE) disease activity and SARS-CoV-2-… SARS-CoV-2 antibody
responses were measured against … SARS-CoV-2 in patients with systemic lupus erythematosus (…

… SARS-CoV-2 vaccine BNT162b2 (BioNTech & Pfizer) side effects in patients with systemic
lupus erythematosus (… patients immunized with BNT162b2 vaccine against SARS-CoV-2, 27% …